RGC
Regencell Bioscience Holdings Ltd
6.20$
+0.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.3% | -0.8% | +1.9% | +3.3% | +2.4% | +4.1% | +4.4% | -3.0% | -4.5% | +5.3% | +7.6% | -1.6% | +4.6% | +2.2% | -1.1% | -100.0% | – | – | – | – | – | – | |
| – | +9.5% | +2.2% | +2.1% | +8.3% | -1.0% | +2.9% | +991.6% | -91.3% | -5.0% | +5.2% | +9.9% | +0.0% | +987.8% | +1.6% | -90.0% | – | – | +178.0% | +2,184.5% | +27.3% | -3.1% | -47.3% | |
| – | +16.6% | -1.0% | +1.9% | +3.1% | +2.6% | +4.2% | -34.8% | +55.9% | -4.5% | +5.3% | +7.5% | -1.6% | -33.3% | +2.6% | +54.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +69.2% | +13.5% | +473.1% | -37.0% | -32.6% | -11.1% | |
| – | -4.6% | +1.6% | -3.2% | +6.6% | -3.1% | -1.6% | +614.5% | -84.9% | -1.3% | +4.6% | +7.1% | +0.9% | +572.4% | +2.4% | -83.1% | -99.8% | +96.0% | +201.8% | +439.6% | -12.8% | -36.8% | -13.5% | |
| – | +13.7% | +1.7% | +4.7% | +1.9% | +2.2% | +6.3% | -42.8% | -13.4% | -15.5% | +1.2% | +9.9% | +3.0% | +32.4% | +2.9% | -19.4% | -100.0% | +107.8% | +70.0% | +451.5% | -17.6% | -36.4% | -15.4% | |
| – | +33.9% | -15.3% | -16.2% | +14.5% | +4.5% | -11.8% | +10.4% | -31.1% | +2.5% | +51.0% | +1.7% | -9.8% | +10.6% | +1.5% | -21.1% | -100.1% | – | – | – | – | – | – | |
| – | +18.0% | +31.9% | +23.2% | +6.8% | -10.4% | +10.7% | +23.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.1% | -53.6% | +7.0% | -5.3% | +320.1% | -79.7% | +27.8% | -51.8% | -23.6% | +308.1% | +12.2% | -32.5% | +41.8% | +11.2% | -24.1% | -100.2% | – | – | – | – | – | – | |
| – | +36.0% | -51.2% | +1.7% | -5.0% | +324.6% | -79.3% | +23.8% | -21.3% | -63.7% | +415.3% | +17.3% | -31.4% | +36.4% | +11.1% | -8.6% | -100.0% | – | – | – | – | – | – | |
| – | +58.1% | -55.7% | +11.0% | -5.5% | +322.1% | -80.2% | +32.6% | -18.7% | -48.1% | +259.3% | +8.9% | -33.0% | +45.3% | +11.1% | -34.1% | -100.3% | – | – | – | – | – | – | |
| – | -2.2% | -43.9% | +5.9% | -7.7% | +214.4% | -70.4% | +156.1% | -31.2% | -26.3% | +62.6% | +11.1% | -16.7% | +20.3% | +8.9% | -8.5% | -100.1% | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.